CD169+ macrophages have previously been shown to be anti-inflammatory, wherein absence of these macrophages led to over-inflammation in bacterial infection or ischemia-reperfusion injury (Karasawa et al, 2015; Svedova et al, 2017). The gene discussed is SIGLEC1; the disease is bacterial infectious disease.